OREMAVEN
XMM 7,722.00 -2.63% YTD +5.6% OM ASX 450.55 -2.56% YTD +0.1% OM PRECIOUS 349.20 -2.24% YTD +2.5% OM EX-PREC 418.91 -2.72% YTD -1.1% XAU 4,115.59 +2.31% YTD -4.9% GLD 375.49 +0.81% YTD -5.2% GDX 85.75 +1.37% YTD -0.0% SIL 77.33 -1.00% YTD -7.3% COPX 70.23 -5.81% YTD -1.8% URNM 40.07 -2.79% YTD -27.0%
2026-11-06

← EQR management

Full background report

Kevin MacNeill

Head of Operational Excellence

Career chronology

  • Named in July 2026 issuer presentation; exact role start not established: EQ Resources — Head of Operational Excellence. EQR investor presentation July 2026 (PDF page 5, leadership slide)

Industrial safety

Mt Carbine safety frequency

FY2025–September 2026 · issuer reported · high materiality

EQR reported Mt Carbine lost-time injury frequency increased from 36.6 in FY2025 to 43.0 in FY2026 and then fell to 34.8 at September 2026. The company reported safety audits and new controls; effectiveness over a longer period remains unestablished.

Attribution: Role overlaps event; causation unproven. Company and site-level measures during this person’s reported role; individual causal responsibility and exact incident-level oversight are not established.

Relevance: Material operating and workforce-safety context.

Annual report FY2026 (Physical PDF page 6, printed page 4, safety section); September 2026 quarterly activities (PDF page 4, Health and Safety)

Barruecopardo safety frequency

FY2025–September 2026 · issuer reported · high materiality

EQR reported Barruecopardo lost-time injury frequency declined from 22.5 in FY2025 to 15.8 in FY2026, then increased to 22.3 at September 2026. The company reports continued safety sessions and environmental monitoring.

Attribution: Role overlaps event; causation unproven. Site-level outcomes overlap the person’s reported role; the evidence does not establish personal causation or responsibility for any particular injury.

Relevance: Relevant context for operating oversight.

Annual report FY2026 (Physical PDF page 6, printed page 4, safety section); September 2026 quarterly activities (PDF page 3, Health and Safety)

Evidence gaps

  • This is a partial public-source screen; independent credentials, exact role and employer tenure, and person-specific prior-employer outcomes remain incompletely verified.

  • Separate person-specific searches for all required subject topics and targeted court/regulator checks remain incomplete.

  • The detailed source and search record is not a criminal, sanctions, regulatory or professional-credential clearance.

  • The exact start date and continuation of the stated role at 31 October 2026 are not independently established.